23 results on '"Michelson, Eric"'
Search Results
2. General Group Discussion: Holter Monitoring
3. Non-Canine Animal Models for Evaluating Antiarrhythmic Efficacy
4. What Animal Models Should Be Used to Define Antiarrhythmic Efficacy? Acute Dog Models
5. How Should One Manage Emergency Drug Requests and Their Data?
6. Assessment of the Hemodynamic and Inotropic Effects of Antiarrhythmic Drugs
7. How Does One Evaluate and Use Outside U.S.A. Data in the New Drug Application?
8. Evaluation of Drug Treatment in Supraventricular Arrhythmias
9. How Should Long-Term Safety of a New Antiarrhythmic Drug Be Determined?
10. What Baseline Electrophysiologic Data Should Be Obtained in a Pharmacologic Study of an Antiarrhythmic Drug?
11. Role of Electrophysiology Testing to Define Drug Efficacy
12. What Should the Study Design Be to Test New Antiarrhythmic Drugs in Patients with Acute Myocardial Infarction, Digitalis Toxicity and Other Acute Problems
13. Proposed New Means of Evaluating Anti-Arrhythmic Drugs
14. Evaluation of Antiarrhythmic Drugs. Should the Lown Classification Be Used as a Measure of Efficacy?
15. Acute Drug Testing as a Part of a Systematic Approach to Antiarrhythmic Drug Therapy
16. Parallel or Crossover Designs in Evaluation of Antiarrhythmic Therapy
17. Long-Term Ambulatory Electrocardiographic Recording in the Determination of Efficacy of New Antiarrhythmic Agents
18. How Should Holter Monitoring Analysis Be Performed?
19. Defining the Pharmacodynamics and Pharmacokinetics of New Antiarrhythmic Drugs
20. Description of Chronic Canine Myocardial Infarction Models Suitable for the Electropharmacologic Evaluation of New Antiarrhythmic Drugs
21. Relationships between Effects on Cardiac Electrophysiology and Antiarrythmic Efficacy
22. How to Evaluate a New Antiarrhythmic Drug: The Challenge of Sudden Cardiac Death
23. Introduction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.